Vitamin D in Diabetic Children

Assessment of Vitamin D in Children With Type 1 Diabetes

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03258086

Enrollment

Registered

2017-08-23

Start date

2016-11-01

Completion date

2017-09-30

Last updated

2018-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D Deficiency

Brief summary

Vitamin D is so-called sunshine vitamin,it is synthesized in the skin during exposure to the ultraviolet rays in sunlight so it has been suggested that ∼ 5-30 minutes of sun exposure between 10:00 a.m. and 3:00 p.m. at least twice per week on the skin of the face, arms, back, or legs (without sunscreen) is usually adequate for vitamin D synthesis. Vitamin D is also found in plants (mainly mushrooms and yeast) and in a few foods such as fatty fish. Vitamin D supplement is recommended in all infants until enough formula, milk, or other food sources are ingested to sufficiently provide 400 IU/day to prevent vitamin D deficiency. Type 1 diabetes is an autoimmune disease, and the self immune system plays a central role in the destruction of the beta cell of pancrease.

Interventions

DIAGNOSTIC_TESTblood sample test

blood sample will be taken from all diabetic children for assessment of vitamin D level

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

5 Years to 15 Years

Healthy volunteers

Inclusion criteria

* Age (5 years - 15 years ). * Type 1 diabetes patients.

Exclusion criteria

* Patients aged more than 15 years, less than 2 years. * Type 2 diabetes. * Neonatal diabetes. * Patients with any complications from diabetes.

Design outcomes

Primary

Measure	Time frame
Assessment of vitamin D level (ng/ml)	24 hours

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026